| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |